How to use the speech recognition tool?

NCT02065011

An Open-Label Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B

An Open-Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B.

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2015-11-27
  • Closing Date: 2035-03-20

Criteria

Inclusion: Provide signed and dated written informed consent (and if appropriate assent) and any locally required authorization eg, Health Insurance Portability and Accountability Act (HIPAA). Must have been enrolled in Protocol TDU13600 Must have received a subreti

Exclusion: Did not receive UshStat® as part of the TDU13600 protocol.

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: